May 5, 2015, 00:00
by
Michael Croft
NEW YORK, NY - May 5, 2015 - Medidata (NASDAQ: MDSO), the leading global provider of cloud-based solutions for clinical research in life sciences, today announced the completion of an open-source connector linking Apple® ResearchKitTM with the Medidata Clinical Cloud® platform
Integration Enables the Secure Collection
of Data from ResearchKit Apps, Furthers Medidata's Efforts to Drive
Adoption of Mobile Health Devices in Clinical Trials
NEW YORK, NY - May 5, 2015 - Medidata (NASDAQ: MDSO), the
leading global provider of cloud-based solutions for clinical
research in life sciences, today announced the completion of an
open-source connector linking Apple® ResearchKitTM with
the Medidata Clinical
Cloud® platform. This mechanism will enable life sciences
companies and academic institutions to map data generated by
ResearchKit apps into Medidatas secure, regulatory-compliant
environment, integrating the data with other information collected
in clinical trials.
Medidata has released the source code for the connector on GitHub®, the worlds largest open
source community, enabling life sciences researchers to create
connections between ResearchKit apps and the Medidata platform. In
doing so, Medidata is furthering efforts to accelerate drug
development by helping clinical trial sponsors-and their contract
research organization partners-gather more and better data on
patients health status and response to therapeutic
interventions.
Apple is a key part of the ecosystem that defines the new era
of mobile health. Were excited that they are leveraging their
market and technology leadership to help collect high-quality
research data, said Glen de Vries, Medidatas president.
ResearchKit provides a terrific approach for dealing with the
last mile for in-life data, and linking ResearchKit-based apps to
the Medidata Cloud means that studies can now be planned and
managed on our integrated platform, where virtually every possible
source of clinical data can be automatically integrated-regardless
of whether the source is a healthcare professional or a patient,
and regardless of whether the data was gathered in a clinic or the
patients home.
ResearchKit, Apples open-source framework that enables
developers and researchers to create apps for medical research,
brings together rich sets of personal data from iOS apps. To
further the impact that this data can have in clinical research,
Medidata has developed a mechanism allowing study builders to map
the data generated from ResearchKit apps to studies in
Medidata Rave®. Facilitating data capture and flow-as well as
the incorporation of third-party lab and medical record
data-directly into the Medidata Clinical Cloud, this initiative is
part of Medidatas ongoing efforts to unify mobile health devices
with cloud-based technologies in a clinical trial setting.
Making this open-source connector to ResearchKit available is
consistent with everything weve done with our platform to date in
order to integrate direct-from-patient data with traditional
clinical data and provide a more holistic view of patients
response to therapy and progression of disease, said Mike Capone,
Medidatas chief operating officer. As a company, Medidata is
deeply committed to leveraging innovative technologies to make the
science of drug development better, and we believe that initiatives
such as this will result in better data, enhanced patient
experiences and more efficient trials.
About Medidata
Medidata is the leading
global provider of cloud-based solutions for clinical research in
life sciences, transforming clinical development through its
advanced applications and intelligent data analytics. The Medidata
Clinical Cloud® brings new levels of productivity and quality to
the clinical testing of promising medical treatments, from study
design and planning through execution, management and reporting. We
are committed to advancing the competitive and scientific goals of
global customers, which include over 90% of the top 25 global
pharmaceutical companies; innovative biotech, diagnostic and device
firms; leading academic medical centers; and contract research
organizations.
Connect with Medidata:
Medidata Contacts
Investor: Hulus Alpay, Medidata Solutions, +1
212-419-1025, halpay@mdsol.com
Media: Nicole Pariser, Medidata
Solutions, +1 212-659-1069, npariser@mdsol.com